Valuation: Illumina, Inc.

Market Cap 38.56B 33.9B 31.93B 29.18B 54.53B 3,700B 54.99B 382B 148B 1,885B 145B 142B 6,123B P/E 2026 *
51.6x
P/E 2027 * 43.2x
Enterprise Value 38.45B 33.79B 31.84B 29.09B 54.37B 3,689B 54.83B 381B 148B 1,879B 144B 141B 6,105B EV / Sales 2026 *
8.31x
EV / Sales 2027 * 7.64x
Free-Float
74.97%
Yield 2026 *
-
Yield 2027 * -
1 day+7.25%
1 week+19.64%
Current month+28.21%
1 month+24.84%
3 months+66.07%
6 months+121.26%
Current year+108.83%
1 week 234.57
Extreme 234.57
277.95
1 month 200.01
Extreme 200.01
277.95
Current year 112.65
Extreme 112.65
277.95
1 year 88
Extreme 88
277.95
3 years 68.7
Extreme 68.7
277.95
5 years 68.7
Extreme 68.7
431.11
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 24/09/2023
Director of Finance/CFO 50 14/04/2024
Chief Tech/Sci/R&D Officer 55 28/05/2025
Director TitleAgeSince
Director/Board Member 65 27/07/2016
Director/Board Member 66 31/12/2016
Director/Board Member 65 04/02/2019
Date Insider Type Main position Quantity % Market Cap. Importance
08/09/26 Free

General Counsel

29,377 0.0195%
05/09/26 Tax

Chief Technology Officer

-408 0.0003%
04/09/26
Corvex Management LP
SellCompany -119,501 0.0791%
Change 5-day change 1-year change 3-year change Capi.($)
+7.25%+19.64%+175.64%+106.81% 38.56B
+1.97%+4.62%+44.42%+34.93% 246B
+1.00%+7.40%+17.95%-9.90% 156B
+0.31%+4.51%-10.77%+38.63% 141B
+0.13%+1.75%-54.26%-16.64% 64.66B
-1.26%-3.98%+14.97%+23.07% 50.04B
+0.03%-3.00%-20.96%-21.61% 47.18B
+4.55%+12.46%+37.24%+55.14% 46.61B
+2.31%+2.79%+43.81%+59.96% 41.32B
-0.18%-2.79%-19.49%+62.43% 31.8B
Average +1.35%+2.88%+22.85%+33.28% 86.26B
Weighted average by Cap. +0.94%+3.38%+21.05%+26.31%

Financials

2026 *2027 *
Net sales 4.62B 4.06B 3.83B 3.5B 6.54B 444B 6.59B 45.84B 17.78B 226B 17.36B 16.98B 734B 4.92B 4.32B 4.07B 3.72B 6.96B 472B 7.01B 48.76B 18.91B 240B 18.47B 18.07B 781B
Net income 772M 679M 639M 584M 1.09B 74.09B 1.1B 7.66B 2.97B 37.74B 2.9B 2.84B 123B 912M 801M 755M 690M 1.29B 87.47B 1.3B 9.04B 3.5B 44.55B 3.42B 3.35B 145B
Net Debt -116M -102M -95.73M -87.48M -163M -11.09B -165M -1.15B -444M -5.65B -434M -425M -18.36B -976M -858M -808M -739M -1.38B -93.65B -1.39B -9.68B -3.75B -47.7B -3.66B -3.58B -155B
Logo Illumina, Inc.
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows: - product sales (85.4%): tools and instruments for sequencing, genotyping, genetic expression, etc.; - sales of services (14.6%). Net sales are distributed geographically as follows: the United States (51.6%), Americas (3.8%), Europe (29.1%), Asia/Pacific/Middle East/Africa (9.9%) and China/Taiwan/Hong Kong (5.6%).
Employees
8,625
Date Price Change Volume
24/09/26 US$273.87 +7.24% 3,445,034
23/09/26 US$255.38 +3.20% 2,301,113
22/09/26 US$247.46 +3.62% 2,642,518
21/09/26 US$238.82 -0.33% 3,188,895
18/09/26 US$239.62 -2.27% 32,588,763
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
255.38USD
Average target price
202.65USD
Spread / Average Target
-20.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock